WASHINGTON (Reuters) – Further full U.S. approvals for COVID-19 vaccines could come within weeks, with separate approval for children under 12 as soon as mid-autumn, the nation’s top infectious disease official said on Tuesday, one day after Pfizer-BioNTech won wider FDA approval for its shot.
Dr. Anthony Fauci, President Joe Biden’s top medical officer and the head of the National Institutes of Allergy and Infectious Diseases, told MSNBC he expects Moderna and Johnson & Johnson to secure full Food and Drug Administration approval relatively soon, possibly within several weeks to one month.
“I think there’s a reasonable chance” that Pfizer or Moderna could get FDA approval for younger children before the upcoming holiday season, he told NBC News’ “Today” program. “Hopefully by the mid-late fall and early winter.”
(Reporting by Susan Heavey; Editing by Andrew Heavens)
